Chemo Pharma Laboratories Ltd.
| BSE: 506365 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE320M01019 |
| BSE 00:00 | 08 Aug | 37.85 |
0 (0.00%) |
OPEN
38.00 |
HIGH
38.00 |
LOW
36.10 |
| NSE 05:30 | 01 Jan | Chemo Pharma Laboratories Ltd |
| OPEN | 38.00 |
| PREVIOUS CLOSE | 37.85 |
| VOLUME | 329 |
| 52-Week high | 49.45 |
| 52-Week low | 21.70 |
| P/E | 199.21 |
| Mkt Cap.(Rs cr) | 6 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Chemo Pharma Laboratories Ltd. (CHEMOPHARMALAB) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 918.85 | -0.05 | 966.90 | 733.95 | 220459.67 |
| Divi's Lab. | 3924.65 | -0.53 | 5425.00 | 3365.10 | 104179.83 |
| Cipla | 1040.80 | 0.25 | 1083.15 | 850.00 | 83992.56 |
| Dr Reddy's Labs | 4262.75 | 0.48 | 5078.80 | 3655.00 | 70949.21 |
| Apollo Hospitals | 4455.30 | -1.41 | 5930.70 | 3365.90 | 64058.30 |
| Torrent Pharma. | 1533.30 | -0.49 | 1652.23 | 1242.50 | 51893.01 |
| Piramal Enterp. | 1917.65 | 5.32 | 3013.00 | 1561.00 | 45764.72 |
| Abbott India | 19420.00 | -0.96 | 23902.30 | 15525.00 | 41267.50 |
| Gland Pharma | 2327.60 | 0.88 | 4350.00 | 2180.10 | 38335.57 |
| Biocon | 315.15 | 0.62 | 410.50 | 305.00 | 37836.91 |
| Zydus Lifesci. | 368.15 | 0.96 | 589.70 | 319.40 | 37687.52 |
| Max Healthcare | 374.00 | 0.65 | 472.60 | 285.10 | 36264.16 |
| Alkem Lab | 2979.50 | 0.74 | 4067.70 | 2835.00 | 35619.92 |
| Aurobindo Pharma | 569.30 | 0.89 | 898.55 | 503.40 | 33355.29 |
| Lupin | 679.70 | 1.49 | 1151.20 | 583.05 | 30902.56 |
| Laurus Labs | 565.50 | 1.22 | 723.55 | 433.20 | 30387.14 |
| Ipca Labs. | 1017.90 | 2.63 | 1383.55 | 831.40 | 25824.12 |
| Glaxosmi. Pharma | 1447.40 | 0.17 | 1917.00 | 1372.80 | 24520.40 |
| Syngene Intl. | 581.70 | 0.64 | 686.00 | 508.10 | 23351.18 |
| Fortis Health. | 268.50 | 0.36 | 313.80 | 219.80 | 20270.68 |
Quick Links for Chemo Pharma Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
